CSIMarket Company Name, Ticker, Competitors, else..
 
Ocean Biomedical Inc   (NASDAQ: OCEA)
 

Ocean Biomedical Inc's Suppliers Performance

OCEA's Supply Chain



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

 
OCEA Costs vs Sales of Suppliers Growth

• More on OCEA Suppliers






Ocean Biomedical Inc's Comment on Supply Chain


The company sources discoveries from academic and research institutions, specifically partnering with Brown University and Rhode Island Hospital. It licenses assets from these institutions and has experience in evaluating innovations and advancing products through clinical development. For drug development, the company utilizes contract research organizations (CROs) and contract manufacturing organizations (CMOs) to advance product candidates. Its business model involves housing each program in a subsidiary to provide economic incentives to partner institutions and researchers, including offering equity in future programs. The company employs a multi-disciplinary approach across programs, leveraging expertise and knowledge, with examples including oncology and fibrosis programs based on chitinase biology and overlapping immunology and oncology therapeutic strategies.

Ocean Biomedical Inc's Comment on Supply Chain


The company sources discoveries from academic and research institutions, specifically partnering with Brown University and Rhode Island Hospital. It licenses assets from these institutions and has experience in evaluating innovations and advancing products through clinical development. For drug development, the company utilizes contract research organizations (CROs) and contract manufacturing organizations (CMOs) to advance product candidates. Its business model involves housing each program in a subsidiary to provide economic incentives to partner institutions and researchers, including offering equity in future programs. The company employs a multi-disciplinary approach across programs, leveraging expertise and knowledge, with examples including oncology and fibrosis programs based on chitinase biology and overlapping immunology and oncology therapeutic strategies.







OCEA's vs. Suppliers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Ocean Biomedical Inc 0.07 0.00 58.86 22
SUBTOTAL 0.00 0.00 0.00 -


Sources: Ocean Biomedical Inc 's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Ocean Biomedical Inc ’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.